Your browser is no longer supported. Please, upgrade your browser.
Settings
FCSC Fibrocell Science, Inc. daily Stock Chart
FCSC [NASD]
Fibrocell Science, Inc.
Index- P/E- EPS (ttm)-1.41 Insider Own0.17% Shs Outstand10.00M Perf Week4.12%
Market Cap20.20M Forward P/E- EPS next Y-1.04 Insider Trans0.00% Shs Float9.74M Perf Month4.66%
Income-11.90M PEG- EPS next Q-0.16 Inst Own28.10% Short Float11.64% Perf Quarter-14.04%
Sales- P/S- EPS this Y78.30% Inst Trans1.01% Short Ratio1.14 Perf Half Y7.45%
Book/sh0.62 P/B3.26 EPS next Y-5.10% ROA-69.20% Target Price16.00 Perf Year-14.04%
Cash/sh1.13 P/C1.79 EPS next 5Y- ROE-135.70% 52W Range1.45 - 3.45 Perf YTD34.67%
Dividend- P/FCF- EPS past 5Y38.10% ROI- 52W High-42.03% Beta1.71
Dividend %- Quick Ratio3.60 Sales past 5Y- Gross Margin- 52W Low37.93% ATR0.12
Employees23 Current Ratio3.60 Sales Q/Q- Oper. Margin- RSI (14)50.78 Volatility6.07% 6.93%
OptionableNo Debt/Eq0.00 EPS Q/Q27.10% Profit Margin- Rel Volume0.04 Prev Close2.02
ShortableYes LT Debt/Eq0.00 EarningsMay 15 BMO Payout- Avg Volume996.40K Price2.00
Recom- SMA203.12% SMA50-3.51% SMA200-1.53% Volume10,513 Change-0.99%
Jan-16-18Reiterated H.C. Wainwright Buy $7.60 → $6
Sep-26-17Reiterated H.C. Wainwright Buy $5.70 → $7.60
Mar-07-17Initiated Rodman & Renshaw Buy $2
Mar-11-16Reiterated Wedbush Neutral $6 → $4
Dec-22-15Initiated ROTH Capital Buy $14
Sep-28-15Downgrade Wedbush Outperform → Neutral
Jun-13-19 09:50AM  Savara Plunges on Failure of Late-Stage Study on Molgradex Zacks
May-30-19 08:44AM  Fibrocell Up on FDA Designation for Gene Therapy Candidate Zacks
08:00AM  Fibrocell to Present at BIO International Convention 2019 GlobeNewswire
May-29-19 09:30AM  Is Fibrocell Science (FCSC) Stock Outpacing Its Medical Peers This Year? Zacks +10.70%
08:00AM  Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEB GlobeNewswire
May-16-19 10:03AM  The Zacks Analyst Blog Highlights: Limbach, Health Insurance, Fibrocell, Camden and First Business Zacks -7.13%
May-15-19 09:34AM  Fibrocell (FCSC) Miss Estimates for Earnings & Revenues in Q1 Zacks
08:11AM  Small Business Optimism Hits 4-Month High in April: 5 Picks Zacks
07:30AM  Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational Highlights GlobeNewswire
May-13-19 09:30AM  Is Fibrocell Science (FCSC) Outperforming Other Medical Stocks This Year? Zacks
08:44AM  Blueprint Medicines (BPMC) Q1 Earnings & Sales Lag Estimates Zacks
May-10-19 03:27PM  Global Blood (GBT) Reports Narrower-Than-Expected Loss in Q1 Zacks -5.33%
02:54PM  Agenus (AGEN) Q1 Earnings Beat Estimates, Revenues Miss Zacks
10:11AM  Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil Zacks
10:00AM  Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints Zacks
08:34AM  Intrexon (XON) Reports In-Line Q1 Loss, Misses on Revenues Zacks
May-09-19 06:17PM  Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates Zacks
03:21PM  Amicus' (FOLD) Earnings & Revenues Miss Estimates in Q1 Zacks
03:03PM  IVERIC bio's (ISEE) Q1 Loss Narrows, Gene Therapy in Focus Zacks
11:05AM  Sarepta (SRPT) Q1 Earnings Top Estimates, Exondys 51 Sales Up Zacks
09:03AM  Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks
08:00AM  Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights GlobeNewswire
06:57AM  AMAG Q1 Loss Wider Than Expected, Revenues Lag Estimates Zacks
May-07-19 01:51PM  Mylan's (MYL) Q1 Earnings Beat Estimates, Revenues Miss Zacks
08:56AM  Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q1 Zacks
Apr-30-19 05:50PM  Fibrocell Science (FCSC) Flat As Market Gains: What You Should Know Zacks
Apr-25-19 09:30AM  Is Fibrocell Science (FCSC) Stock Outpacing Its Medical Peers This Year? Zacks +5.24%
Apr-17-19 09:14AM  These 2 Biotech Stocks Are No Longer 'Off the Radar' TheStreet.com
07:48AM  Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal Zacks
Apr-16-19 07:26PM  ProQR Initiates Dosing in Phase II/III Eye Disorder Study Zacks -12.99%
10:59AM  Fibrocell Out-licenses Skin Disease Gene Therapy, Stock Rises Zacks
Apr-15-19 01:22PM  Fibrocell signs $135M deal to advance therapy for 'butterfly children' American City Business Journals +42.70%
06:30AM  Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy GlobeNewswire
Apr-03-19 08:00AM  Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors GlobeNewswire
Mar-27-19 07:30AM  Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007 GlobeNewswire -26.00%
Mar-20-19 08:00AM  Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019 GlobeNewswire +19.29%
Feb-06-19 08:00AM  Fibrocell to Present at 21st Annual BIO CEO & Investor Conference GlobeNewswire
Jan-16-19 08:00AM  Fibrocell to Present at Phacilitate Leaders World 2019 GlobeNewswire +6.32%
Dec-11-18 08:00AM  Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation GlobeNewswire
Dec-04-18 02:16PM  What Kind Of Shareholders Own Fibrocell Science Inc (NASDAQ:FCSC)? Simply Wall St.
Nov-19-18 08:30AM  Market Trends Toward New Normal in Fibrocell Science, Sears Hometown and Outlet Stores, Apellis Pharmaceuticals, Sigma Labs, Highpower International, and Nicholas Financial Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-13-18 08:00AM  Fibrocell Reports Third Quarter 2018 Financial Results and Recent Highlights GlobeNewswire
Nov-09-18 02:08PM  Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3 Zacks
Nov-08-18 08:00AM  Fibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent Highlights GlobeNewswire
Oct-25-18 08:00AM  Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007 GlobeNewswire
Sep-26-18 08:00AM  Fibrocell to Present at Upcoming Industry and Investor Conferences GlobeNewswire
Sep-25-18 08:00AM  Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
Sep-05-18 08:00AM  Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma GlobeNewswire
Aug-09-18 08:00AM  Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights GlobeNewswire +5.91%
06:30AM  Fibrocell Science, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM  Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights GlobeNewswire
Jul-31-18 05:09PM  What's in Store for Intrexon (XON) This Earnings Season? Zacks
Jul-25-18 07:35AM  Free Technical Research on Evolus and Three More Generic Drugs Equities ACCESSWIRE
Jul-05-18 04:05PM  Fibrocell Announces Closing of $4.0 Million Registered Direct Offering GlobeNewswire
Jul-02-18 11:05AM  Chester County gene therapy company expects $4M direct from direct stock offering American City Business Journals -7.21%
09:00AM  Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
Jun-01-18 08:16AM  Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO Benzinga -6.25%
07:39AM  Chester County gene therapy company completes $6M stock sale American City Business Journals
06:57AM  Fibrocell Science (FCSC) Sees Hammer Chart Pattern: Time to Buy? Zacks
May-31-18 04:05PM  Fibrocell Announces Closing of $6.0 Million Registered Direct Offering GlobeNewswire
May-29-18 09:20AM  Fibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire -11.50%
May-24-18 08:56AM  Fibrocell Announces One-for-Five Reverse Stock Split GlobeNewswire -5.81%
May-23-18 07:40AM  Blog Exposure - Fibrocell Presented Update on Interim Results and Progress of its Phase-1/2 Clinical Trial of FCX-007 at International Investigative Dermatology Meeting ACCESSWIRE
May-21-18 08:59AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga -5.00%
07:00AM  Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
May-17-18 08:27AM  Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More Benzinga +60.43%
May-16-18 04:05PM  Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting GlobeNewswire
May-10-18 08:00AM  Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights GlobeNewswire
May-03-18 08:00AM  Fibrocell to Host Conference Call and Webcast on Thursday, May 10, 2018 to Discuss First Quarter 2018 Financial Results and Recent Highlights GlobeNewswire
May-02-18 10:54AM  What's in Store for Intrexon (XON) This Earnings Season? Zacks
Apr-18-18 08:00AM  Fibrocell Announces Review of Strategic Alternatives GlobeNewswire
Apr-10-18 08:00AM  Fibrocell to Present at 6th Annual Cell & Gene Therapy Investor Day and 2018 World Orphan Drug Congress USA GlobeNewswire +9.77%
Mar-19-18 08:00AM  Fibrocell Reports 2017 Financial Results and Recent Highlights GlobeNewswire -7.35%
07:42AM  Does Fibrocell Science Incs (NASDAQ:FCSC) Past Performance Indicate A Stronger Future? Simply Wall St.
06:30AM  Fibrocell Science, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-18 08:00AM  Fibrocell to Host Conference Call and Webcast on Monday, March 19, 2018 to Discuss 2017 Financial Results and Recent Highlights GlobeNewswire +5.26%
Mar-06-18 08:00AM  Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma GlobeNewswire
Mar-02-18 12:32PM  Intrexon (XON) Q4 Loss Narrower Than Expected, Revenues Beat Zacks +7.69%
11:02AM  NasdaqGS Top Growth Stocks Duluth Holdings And More Simply Wall St.
Feb-26-18 09:04PM  What's in Store for Intrexon (XON) This Earnings Season? Zacks
Feb-06-18 08:00AM  Fibrocell to Present at 20th Annual BIO CEO & Investor Conference GlobeNewswire
Feb-05-18 08:00AM  Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma GlobeNewswire
Feb-01-18 07:50AM  Wired News Fibrocell Science Gets FDA Allowance to Start Pediatric Enrollment in Phase-1/2 Clinical Trial of FCX-007 for the Treatment of RDEB ACCESSWIRE
Jan-30-18 08:26AM  What's in Store for Cardinal Health (CAH) in Q2 Earnings? Zacks
08:00AM  Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) GlobeNewswire
Jan-24-18 08:00AM  Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018 GlobeNewswire
Jan-23-18 05:33PM  Fibrocell Science Inc (NASDAQ:FCSC) And The Healthcare Sector Outlook 2018 Simply Wall St.
Jan-04-18 08:05AM  Fibrocell Science Has New Capital in Hand, Updates Investors on Pipeline Products ACCESSWIRE -6.92%
Jan-02-18 07:29PM  Why Fibrocell Science Incs (NASDAQ:FCSC) Investor Composition Impacts Your Returns Simply Wall St. +7.81%
Dec-14-17 01:22PM  ETFs with exposure to Fibrocell Science, Inc. : December 14, 2017 Capital Cube +7.23%
Dec-12-17 12:10PM  Chester County gene therapy company completes $10.5M stock sale American City Business Journals -6.12%
Dec-11-17 04:01PM  Fibrocell Announces Closing of $10.5 Million Underwritten Public Offering GlobeNewswire
Dec-08-17 07:13PM  Should You Worry About Fibrocell Science Incs (FCSC) CEO Pay Check? Simply Wall St.
Dec-07-17 11:36AM  Fibrocell Science Inc (FCSC) Feels the Heat of Share Dilution SmarterAnalyst -32.54%
07:00AM  Fibrocell Announces Pricing of $10.5 Million Underwritten Public Offering GlobeNewswire
Nov-29-17 05:57PM  Was Fibrocell Science Incs (FCSC) Earnings Growth Better Than Industry? Simply Wall St.
Nov-13-17 08:30AM  Fibrocell Science reports 3Q loss Associated Press -6.82%
08:00AM  Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights GlobeNewswire
06:05AM  Fibrocell Science, Inc. to Host Earnings Call ACCESSWIRE
Nov-10-17 08:49AM  Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss Zacks
Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products for the treatment of chronic inflammation and degenerative diseases of human joints. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was incorporated in 1992 and is based in Exton, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maslowski John MichaelCEOAug 22Buy2.063,0006,1873,164Aug 23 12:34 PM